The boom in interest and use of weight loss and diabetes drugs — many classified as GLP-1 drugs — have investors curious as to what markets and stocks will come out on top. A survey carried out by Stifel Financial (SF) shows a real risk to many companies in the food sector, as many of the drugs aim to decrease appetite. Conversely, clothing brands seek to gain from the use of these drugs as many consumers will have alter their lifestyles and will be in need of new, slimmer clothing. Stifel Analyst Jim Duffy joins Yahoo Finance to discuss the greater impact of weight loss treatment drugs and the survey's implications "We do expect that there will be less calories consumed, by the projections of our food & beverage team, get to 4% less calories consumed with this adoption. We do think that there's going to be more apparent spend," Duffy says. "Consumers are losing significant amounts of weight on these drugs, some clinical trials, including one released recently from Mounjaro, speaks to greater than 40% of consumers losing more than 10% of their body weight." #youtube #weightloss #stockmarket Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life. Connect with Yahoo Finance: Check the latest news and data at finance.yahoo.com Follow Yahoo Finance on social: Connect with Yahoo Finance: Get the latest news: https://yhoo.it/2fGu5Bb Find Yahoo Finance on Facebook: http://bit.ly/2A9u5Zq Follow Yahoo Finance on Twitter: http://bit.ly/2LMgloP Follow Yahoo Finance on Instagram: http://bit.ly/2LOpNYz Follow Yahoo Finance Premium on Twitter: https://bit.ly/3hhcnmV

Related Videos :







Weight loss drugs likely to boost apparel stocks: Survey [qITKeIOJV]

Weight loss drugs likely to boost apparel stocks: Survey [qITKeIOJV]

The boom in interest and use of weight loss and diabetes drugs — many classified as GLP-1 drugs — have investors curious as to what markets and stocks will come out on top. A survey carried out by Stifel Financial (SF) shows a real risk to many companies in the food sector, as many of the drugs aim to decrease appetite. Conversely, clothing brands seek to gain from the use of these drugs as many consumers will have alter their lifestyles and will be in need of new, slimmer clothing. Stifel Analyst Jim Duffy joins Yahoo Finance to discuss the greater impact of weight loss treatment drugs and the survey's implications "We do expect that there will be less calories consumed, by the projections of our food & beverage team, get to 4% less calories consumed with this adoption. We do think that there's going to be more apparent spend," Duffy says. "Consumers are losing significant amounts of weight on these drugs, some clinical trials, including one released recently from Mounjaro, speaks to greater than 40% of consumers losing more than 10% of their body weight." #youtube #weightloss #stockmarket Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life. Connect with Yahoo Finance: Check the latest news and data at finance.yahoo.com Follow Yahoo Finance on social: Connect with Yahoo Finance: Get the latest news: https://yhoo.it/2fGu5Bb Find Yahoo Finance on Facebook: http://bit.ly/2A9u5Zq Follow Yahoo Finance on Twitter: http://bit.ly/2LMgloP Follow Yahoo Finance on Instagram: http://bit.ly/2LOpNYz Follow Yahoo Finance Premium on Twitter: https://bit.ly/3hhcnmV

Related Videos :

Aired: December 3rd 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now